Markus W. Sieger's most recent trade in Rafael Holdings Inc - Ordinary Shares - Class B was a trade of 35,000 Class B Common Stock, par value $.01 per share done at an average price of $1.3 . Disclosure was reported to the exchange on May 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rafael Holdings Inc Ordinary | Markus W. Sieger | Director | 27 May 2025 | 35,000 | 190,182 (1%) | 0% | 1.3 | 44,800 | Class B Common Stock, par value $.01 per share | |
| Rafael Holdings Inc Ordinary | Markus W. Sieger | Director | 27 May 2025 | 35,000 | 0 | - | - | Subscription Rights (right to buy) | ||
| Cyclo Therapeutics Inc | Markus W. Sieger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 58,138 | 440,260 | - | 0 | Common Stock | |
| Cyclo Therapeutics Inc | Markus W. Sieger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2024 | 35,022 | 382,122 | - | 0 | Common Stock | |
| Cyclo Therapeutics Inc | Markus W. Sieger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2024 | 18,354 | 347,100 | - | 0 | Common Stock | |
| Cyclo Therapeutics Inc | Markus W. Sieger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 18,067 | 328,746 | - | 0 | Common Stock | |
| Cyclo Therapeutics Inc | Markus W. Sieger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 15,562 | 15,562 | - | - | Stock Option (Right to Buy) |